WUSA 9News Now At 5pm November 18, 2011
two advisory panels suggested the f.d.a. make this move so it is not unexpected but it is still a blow to women some saying this drug is their only option to battle the spreading cancer. >> we know that some patients do benefit, many don't and just have the side effects and again at the moment we don't know how to separate one group from the other. >> it is important to say the drug is still available because it is also used to treat colon, lung and other types of cancer but the f.d.a. ruling will most likely influence insurance coverage especially for breast cancer. however, late to...
Source: archive.org